Expression from the nuclear genome of genes that normally are expressed only from the mitochondrial genome is referred to as allotopic expression (AE). Biomedically engineered AE has been suggested as a possible future tool in gene therapy of certain mitochondria-related diseases (de Grey 2000), however this view is controversial (Oca-Cossio et al 2003).